货号:A458424
同义名:
Schizandrin; Schizandrol
Schisandrin是一种从五味子中提取的天然木脂素,具有抗氧化、抗癌、保肝和抗炎作用。它也可用于研究大鼠记忆障碍的逆转。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | P-gp ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elacridar | ✔ | BCRP | 99%+ | ||||||||||||||||
| Zosuquidar 3HCl |
++
P-gp, Ki: 60 nM |
99%+ | |||||||||||||||||
| SC144 | ✔ | 99%+ | |||||||||||||||||
| Tariquidar |
+++
P-gp, Kd: 5.1 nM |
98% | |||||||||||||||||
| Schizandrin B | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Schizandrin is a major bioactive constituent of Schisandra chinensis (Turcz.) Baill with antioxidant and anti-inflammatory properties. Schizandrin prevented LPS-induced injury in the H9c2 cells and promoted the recovery of myocardial tissues by enhancing cell viability and migration[3]. Sch A specifically reverses P-gp-mediated DOX resistance in MCF-7/DOX cells by blocking P-gp, NF-κB, and Stat3 signaling. Inhibition of P65 and Stat3 shows potent anti-MDR (Multidrug resistance) effect on MCF-7/DOX cells[4]. Schizandrin (1 and 10 mg/kg, p.o.) significantly reversed the scopolamine-induced impairment of spatial memory. Similarly, schizandrin (1 mg/kg, p.o.) significantly reversed the scopolamine-induced impairment of the passive avoidance response. Moreover, in mice, schizandrin (1 and 10 mg/kg, p.o.) enhanced tremors induced by oxotremorine, a muscarinic M(1) receptor agonist[5]. Pretreatment of the cortical cell cultures with schizandrin (10, 100 microM) for 2 h significantly protected cortical neurons against Glu-induced excitotoxicity. The neuroprotective activity of schizandrin was the most potent at the concentration of 100 microM. In addition, schizandrin diminished the intracellular Ca2+ influx, inhibited the subsequent overproduction of nitric oxide (NO), reactive oxygen species (ROS), and cytochrome c, and preserved the mitochondrial membrane potential. Furthermore, schizandrin also increased the cellular level of glutathione (GSH) and inhibited the membrane lipid peroxidation malondialdehyde (MDA)[6]. Schizandrin can be used to treat inflammatory and atopic diseases through the inhibition of TSLP(Thymic stromal lymphopoietin) [7]. |
| Concentration | Treated Time | Description | References | |
| Primary cortical neurons | 1 µM | 18 days | Promote neuronal maturation and axon growth | Molecules. 2021 Dec 9;26(24):7466 |
| RAW 264.7 macrophages | 50, 100, 200 µM | 1 hour pretreatment followed by 24 hours LPS stimulation | Inhibited LPS-induced NO and PGE2 production, downregulated iNOS and COX-2 mRNA and protein expression | Int J Mol Med. 2018 Jan;41(1):264-274 |
| Bone marrow-derived macrophages (BMMs) | 200 µM | 2 days | To evaluate the effect of Schisandrin A on BMMs apoptosis, results showed 200 μmol/L concentration did not induce apoptosis | Cell Prolif. 2020 Oct;53(10):e12882. |
| BEAS‑2B | 0, 25, 50, 75, 100 µM | 24 hours | SchA reduced the viability of BEAS‑2B cells in a concentration-dependent manner. | Int J Mol Med. 2021 Dec;48(6):214. |
| H1299 | 0, 25, 50, 75, 100 µM | 24 hours | SchA reduced the viability of H1299 cells in a concentration-dependent manner. | Int J Mol Med. 2021 Dec;48(6):214. |
| H1975 | 0, 25, 50, 75, 100 µM | 24 hours | SchA reduced the viability of H1975 cells in a concentration-dependent manner. | Int J Mol Med. 2021 Dec;48(6):214. |
| A549 | 0, 25, 50, 75, 100 µM | 24 hours | SchA reduced the viability of A549 cells in a concentration-dependent manner. | Int J Mol Med. 2021 Dec;48(6):214. |
| Rat chondrocytes | 25, 50 µM | 24 hours | To evaluate the effects of Schisandrin A on IL-1β-induced inflammation and cartilage degradation. Results showed that Schisandrin A could suppress IL-1β-induced production of NO and PGE2, downregulate iNOS and COX2 expression, inhibit MMPs and ADAMTS5 expression, and reverse IL-1β-induced downregulation of Collagen II, Aggrecan, and Sox9. | Front Pharmacol. 2019 Jan 29;10:41 |
| Bone marrow-derived macrophages (BMMs) | 0, 50, 100, 150, 200, 400 µM | 24, 48, 72 hours | To evaluate the effect of Schisandrin A on BMMs cell viability, results showed no significant effect on cell viability below 200 μmol/L | Cell Prolif. 2020 Oct;53(10):e12882. |
| THP-1 cells | 20/40/80 µM | 4 hours | To investigate the effect of SCH on NLRP3 inflammasome activation in THP-1 cells, results showed that SCH could inhibit NLRP3 inflammasome activation. | Chin Med. 2023 Sep 6;18(1):112 |
| Spd2 cells | 5, 10, 20 mM | 48 hours | To evaluate the effect of Schisandrin A on the viability of Spd2 cells. Results showed that Schisandrin A promoted the proliferation of testicular interstitial cells at concentrations of 10–40 mmol/L, with the best effect observed at 10 mmol/L. | Acta Pharm Sin B. 2023 Jun;13(6):2765-2777. |
| Rat colonic smooth muscle cells | 0.5-10 µM | 5 minutes | To investigate the inhibitory effect of Schisandrin on spontaneous contraction of rat colon, results showed that Schisandrin inhibited colonic spontaneous contraction in a concentration-dependent manner with an EC50 of 1.66 μM. | Phytomedicine. 2011 Aug 15;18(11):998-1005 |
| Neural progenitor cells (NPCs) | 1 µM | 72 hours | Promote the proliferation of neural progenitor cells | Molecules. 2021 Dec 9;26(24):7466 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Ovariectomy-induced osteoporosis model | Injection | 100 mg/kg | Every other day for 6 weeks | To evaluate the effect of Schisandrin A on ovariectomy-induced osteoporosis, results showed it significantly reduced bone loss | Cell Prolif. 2020 Oct;53(10):e12882. |
| C57/BL6 mice | Ischemic brain injury model | Intraperitoneal injection | 12 mg/kg | Once daily for 3 weeks | Promote neural progenitor cell proliferation and nerve fiber regeneration | Molecules. 2021 Dec 9;26(24):7466 |
| APP/PS1 transgenic mice | Alzheimer's disease model | Intragastrically | 2 mg/kg/day | Once daily for 2 weeks | Schisandrin ameliorated learning and memory impairments in APP/PS1 mice and significantly decreased Aβ deposition in the hippocampus. Additionally, Schisandrin treatment restored the abnormal levels of neurotransmitters and their metabolites in the brain. | Acta Pharmacol Sin. 2018 Apr;39(4):616-625 |
| C57BL/6 mice | DSS-induced ulcerative colitis model | Gavage | 20, 40, 80 mg/kg/d | Once daily for 7 days | To evaluate the therapeutic effect of SCH on ulcerative colitis, results showed that SCH significantly alleviated colitis symptoms, reduced inflammatory factors, and restored gut microbiota balance. | Chin Med. 2023 Sep 6;18(1):112 |
| Sprague-Dawley rats | OA model induced by anterior cruciate ligament transection and partial medial meniscectomy | Intra-articular injection | 50 μM | Once weekly for one month | To evaluate the protective effects of Schisandrin A on cartilage damage in OA model. Results showed that Schisandrin A significantly alleviated joint damage and reduced cartilage destruction. | Front Pharmacol. 2019 Jan 29;10:41 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.31mL 0.46mL 0.23mL |
11.56mL 2.31mL 1.16mL |
23.12mL 4.62mL 2.31mL |
|
| CAS号 | 7432-28-2 |
| 分子式 | C24H32O7 |
| 分子量 | 432.51 |
| SMILES Code | O[C@]1(C)[C@@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C3=C(OC)C(OC)=C(OC)C=C3C1 |
| 别名 | Schizandrin; Schizandrol; Wuweizins; Schisandrol A; Omija; Magnolia Vine; Gomisins; (+)-Schizandrin; Schizandrol-A |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 1 mg/mL(2.31 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1